ELEVANCE HEALTH INC
ELVNYSE๐ #167 by market capEarnings Jan 26 ยท PostUS Equity
โโ
Quote unavailableTrack ELV
Get earnings, price moves & breaking news on Telegram
24hโ
7dโ
14dโ
30dโ
ytdโ
1yโ
๐ฆMarket Cap
$85.23B
Mid Cap
๐Revenue Growth (YoY)
3.6%
Slowing
๐Gross Margin
โ
๐ตFCF Margin
3.3%
Moderate
โ๏ธP/S Ratio
0.4x
Cheap
Otter Score
โ
Insufficient data
ELEVANCE HEALTH INC
ELVAnalyst Ratings
Total
38
Raised
5
Lowered
3
Avg PT
$470.78
H / L
$523 / $395
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Wells Fargo | Reiterated | Overweight | 2026-10-27 | $473.00 | โ |
TD Cowen | Reiterated | Buy | 2026-10-23 | $495.00 | โ |
Barclays | Reiterated | Overweight | 2026-10-22 | $472.00 | โ |
RBC Capital | Reiterated | Sector Perform | 2026-10-22 | $455.00 | โ |
Morgan Stanley | Reiterated | Equal Weight | 2026-10-22 | $404.00 | โ |
UBS | Reiterated | Buy | 2026-10-22 | $523.00 | โ |
Baird | Reiterated | Neutral | 2026-10-22 | โ | โ |
Guggenheim | Reiterated | Buy | 2026-10-22 | $485.00 | โ |
Leerink Partners | Reiterated | Market Perform | 2026-07-17 | $395.00 | โ |
Bernstein | Reiterated | Outperform | 2026-07-17 | $488.00 | โ |
Truist Securities | Reiterated | Buy | 2026-07-14 | โ | โ |
Cantor Fitzgerald | Reiterated | Overweight | 2026-07-07 | โ | โ |
JP Morgan | Reiterated | Overweight | 2026-06-08 | โ | โ |
Mizuho | Reiterated | Outperform | 2026-06-08 | โ | โ |
B of A Securities | Reiterated | Buy | 2026-06-04 | โ | โ |
Deutsche Bank | Upgraded | Hold โ Buy | 2026-05-20 | $498.00 | โ |
Evercore ISI Group | Reiterated | In Line | 2026-04-23 | โ | โ |
Jefferies | Reiterated | Buy | 2026-04-20 | $391.00 | โ |
Wolfe Research | Upgraded | Peer Perform โ Outperform | 2026-01-08 | $425.00 | โ |
Argus Research | Downgraded | Buy โ Hold | 2025-07-21 | $510.00 | โ |
Stephens & Co. | Reiterated | Overweight | 2024-09-05 | โ | โ |
Loop Capital | Reiterated | Buy | 2023-04-21 | โ | โ |
SVB Leerink | Reiterated | Outperform | 2023-01-26 | โ | โ |
BMO Capital | Reiterated | Outperform | 2022-04-25 | $625.00 | โ |
Credit Suisse | Reiterated | Outperform | 2022-04-21 | $584.00 | โ |
Goldman Sachs | Reiterated | Buy | 2022-04-21 | $451.00 | โ |
Cowen & Co. | Reiterated | Outperform | 2021-04-14 | โ | โ |
SunTrust Robinson Humphrey | Reiterated | Hold | 2020-05-21 | โ | โ |
CFRA | Upgraded | Hold โ Buy | 2020-04-29 | โ | โ |
Bank of America | Downgraded | Buy โ Neutral | 2019-12-06 | โ | โ |
Citigroup | Reiterated | Neutral | 2018-11-06 | โ | โ |
PiperJaffray | Upgraded | Neutral โ Overweight | 2018-01-03 | โ | โ |
Leerink Swann | Reiterated | Outperform | 2017-11-07 | โ | โ |
Stifel Nicolaus | Downgraded | Buy โ Hold | 2017-01-04 | โ | โ |
FBR Capital | Reiterated | Market Perform | 2016-01-28 | โ | โ |
Sterne Agee CRT | Upgraded | Neutral โ Buy | 2015-07-27 | โ | โ |
Susquehanna | Reiterated | Positive | 2015-05-22 | โ | โ |
Oppenheimer | Reiterated | Outperform | 2015-05-01 | โ | โ |
Institution
Wells Fargo
Reiterated ยท Overweight ยท 2026-10-27
$473.00
โ
TD Cowen
Reiterated ยท Buy ยท 2026-10-23
$495.00
โ
Barclays
Reiterated ยท Overweight ยท 2026-10-22
$472.00
โ
RBC Capital
Reiterated ยท Sector Perform ยท 2026-10-22
$455.00
โ
Morgan Stanley
Reiterated ยท Equal Weight ยท 2026-10-22
$404.00
โ
UBS
Reiterated ยท Buy ยท 2026-10-22
$523.00
โ
Baird
Reiterated ยท Neutral ยท 2026-10-22
โ
โ
Guggenheim
Reiterated ยท Buy ยท 2026-10-22
$485.00
โ
Leerink Partners
Reiterated ยท Market Perform ยท 2026-07-17
$395.00
โ
Bernstein
Reiterated ยท Outperform ยท 2026-07-17
$488.00
โ
Truist Securities
Reiterated ยท Buy ยท 2026-07-14
โ
โ
Cantor Fitzgerald
Reiterated ยท Overweight ยท 2026-07-07
โ
โ
JP Morgan
Reiterated ยท Overweight ยท 2026-06-08
โ
โ
Mizuho
Reiterated ยท Outperform ยท 2026-06-08
โ
โ
B of A Securities
Reiterated ยท Buy ยท 2026-06-04
โ
โ
Deutsche Bank
Upgraded ยท Hold โ Buy ยท 2026-05-20
$498.00
โ
Evercore ISI Group
Reiterated ยท In Line ยท 2026-04-23
โ
โ
Jefferies
Reiterated ยท Buy ยท 2026-04-20
$391.00
โ
Wolfe Research
Upgraded ยท Peer Perform โ Outperform ยท 2026-01-08
$425.00
โ
Argus Research
Downgraded ยท Buy โ Hold ยท 2025-07-21
$510.00
โ
Stephens & Co.
Reiterated ยท Overweight ยท 2024-09-05
โ
โ
Loop Capital
Reiterated ยท Buy ยท 2023-04-21
โ
โ
SVB Leerink
Reiterated ยท Outperform ยท 2023-01-26
โ
โ
BMO Capital
Reiterated ยท Outperform ยท 2022-04-25
$625.00
โ
Credit Suisse
Reiterated ยท Outperform ยท 2022-04-21
$584.00
โ
Goldman Sachs
Reiterated ยท Buy ยท 2022-04-21
$451.00
โ
Cowen & Co.
Reiterated ยท Outperform ยท 2021-04-14
โ
โ
SunTrust Robinson Humphrey
Reiterated ยท Hold ยท 2020-05-21
โ
โ
CFRA
Upgraded ยท Hold โ Buy ยท 2020-04-29
โ
โ
Bank of America
Downgraded ยท Buy โ Neutral ยท 2019-12-06
โ
โ
Citigroup
Reiterated ยท Neutral ยท 2018-11-06
โ
โ
PiperJaffray
Upgraded ยท Neutral โ Overweight ยท 2018-01-03
โ
โ
Leerink Swann
Reiterated ยท Outperform ยท 2017-11-07
โ
โ
Stifel Nicolaus
Downgraded ยท Buy โ Hold ยท 2017-01-04
โ
โ
FBR Capital
Reiterated ยท Market Perform ยท 2016-01-28
โ
โ
Sterne Agee CRT
Upgraded ยท Neutral โ Buy ยท 2015-07-27
โ
โ
Susquehanna
Reiterated ยท Positive ยท 2015-05-22
โ
โ
Oppenheimer
Reiterated ยท Outperform ยท 2015-05-01
โ
โ
One row per institution ยท price target from the firm's latest published target